Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 December;64(4) > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 December;64(4):338-45

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  FOCUS ON 64CU: RADIOPHARMACEUTICALS AND CLINICAL APPLICATIONS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 December;64(4):338-45

DOI: 10.23736/S1824-4785.20.03302-6

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

IAEA contribution to the development of 64Cu radiopharmaceuticals for theranostic applications

Amir R. JALILIAN 1 , Joao A. OSSO JR 1, Julia VERA-ARAUJO 1, Vijay KUMAR 2, Matthew J. HARRIS 3, Bianca GUTFILEN 4, Brigitte GUÉRIN 5, Hongyu LI 6, Fedor ZHURAVLEV 7, Rubel CHAKRAVARTY 8, Behrouz ALIREZAPOUR 9, Miguel A. ÁVILA-RODRÍGUEZ 10, Irfan U. KHAN 11, Ibrahim ALJAMMAZ 12, Thaer ASSAAD 13, Gert LUURTSEMA 14, Jeff SMITH 15, Adriano DUATTI 16

 

ACCESS OPTIONS

You can access the full text of this article (PDF and HTML if available) for 48 hours at a price of  € 45,00.

Downloading and printing for personal use allowed.

Regain access


Access as an individual subscriber


Access through your institution

Subscribe to The Quarterly Journal of Nuclear Medicine and Molecular Imaging


Recommend to your librarian

top of page